Prescribing them to the healthy may not have saved lives, but it certainly made money
Back in 1975, Henry Gadsden, the chief executive of the drug company Merck, expressed his frustration that the market for his company's products was limited to those with some treatable illness. Ideally, he said, he would like to "sell to everyone".
Three decades later, his dream would seem to have come true – epitomised by the most profitable class of drugs ever discovered, the cholesterol-lowering statins that are taken by an estimated seven million people in Britain, and tens of millions worldwide.
www.telegraph.co.uk/health/8270156/Statins-for-all-and-billions-for-drug-firms.html
Please check out our website at http://www.lowcarbdiabetic.co.uk/
No comments:
Post a Comment
The lowcarb team value your comments. Thank you for taking the time to contribute to our blog. Please note! negative comments and insults from anonymous idiots, with nothing to add to the debate will not be authorised. However, we welcome constructive criticism.
The best of health to you and yours.
Eddie